43
https://pubmed.ncbi.nlm.nih.gov/38093412
This case series study in a Spanish hospital explores the use of intralesional brentuximab vedotin to treat primary cutaneous T-cell lymphomas.
AI generated summary of Pubmed citation/abstract with PMID 38093412
